Skip to content

Treating tinea cruris with satt e barg panwad.

Evaluation of the efficacy of topical satt-i-barg-e- panwad with vinegar in the treatment of tinea cruris (Quba)-a single blind randomized standard controlled trial. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/071845
Enrollment
40
Registered
2024-08-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

Intervention1: barg e panwad. cassia tora lin with vinegar: form paste mode of application frequency is twice daily drug dosage quantity sufficient contact period 1 hour duration of intervension is 4

Sponsors

shiba fathima
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient diagnosed with tinea cruris (skin of the genitals, inner thighs and buttocks) clinically as well as by KOH mount test without nail and scalp involvement. Patient not taking any other drugs for tinea cruris. Patient who are willing and able to provide informed consent. Patient who are willing and able to understand and follow the protocol for the duration of the study.

Exclusion criteria

Exclusion criteria: 1. Presence of complications such as secondary bacterial infection of the lesions. 2. Patients of tinea at other parts of body except tinea cruris. 3. Patients already on topical and/or systemic antifungal treatment (1 week of topical therapy and/or 4 weeks of systemic antifungal therapy before baseline visit) 4. patients with uncontrolled diabetes. 5. Immunosuppressant patients like AIDS/HIV infection. 6. pregnant and lactating women. 7. Noncompliance with the trial protocol.

Design outcomes

Primary

MeasureTime frame
1. Change in Investigator’s global assessment(IGA) 2. Mycological cure: Clinically suspected cases of tinea cruris will be confirmed by skin scraping and KOH preparation, by visualizing presence or absence of long, narrow, septate and branching hyphae under microscope at baseline and at the conclusion of trial.Timepoint: at the baseline and at 6 week

Secondary

MeasureTime frame
1. Change in TCS (Total clinical score. 2. Changes in Dermatology Life Quality Index.Timepoint: at the end of treatment

Countries

India

Contacts

Public ContactSaba Mamdapur

luqman unani medical college and research center

drmqkhan@yahoo.com9849438319

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026